Correlation Between Viridian Therapeutics and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Viridian Therapeutics and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Kalvista Pharmaceuticals.
Diversification Opportunities for Viridian Therapeutics and Kalvista Pharmaceuticals
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and Kalvista is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.9 times more return on investment than Kalvista Pharmaceuticals. However, Viridian Therapeutics is 1.11 times less risky than Kalvista Pharmaceuticals. It trades about -0.1 of its potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 2,328 in Viridian Therapeutics on August 28, 2024 and sell it today you would lose (225.00) from holding Viridian Therapeutics or give up 9.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Viridian Therapeutics vs. Kalvista Pharmaceuticals
Performance |
Timeline |
Viridian Therapeutics |
Kalvista Pharmaceuticals |
Viridian Therapeutics and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viridian Therapeutics and Kalvista Pharmaceuticals
The main advantage of trading using opposite Viridian Therapeutics and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |